Bayer

News

Mature Woman Experiencing Hot Flush From Menopause

Bayer extends elinzanetant trials to include breast cancer

Bayer has added another clinical trial to its extensive phase 3 programme for oral neurokinin antagonist elinzanetant, hoping to show that it can treat vasomotor symptoms (VMS) in breast ca

News

Bayer get EU nod for extended use of contraceptive Mirena

Bayer's big-selling contraceptive Mirena has been approved in Europe to provide up to eight years of pregnancy protection, which the company says is the longest of any device of its kind.

News

Bayer's Vividion unit forges $930m cancer alliance with Tavr...

Bayer's quest to revamp its drug discovery engine continues apace, with the company's recently acquired Vividion subsidiary forging an alliance with Tavros Therapeutics, aimed at finding ne

News

Report claims Bayer is already hunting for a new CEO

Bayer chief executive Werner Baumann has been under fire from investors since he spearheaded the acquisition of agrochemical company Monsanto for $63 billion, exposing the group to multibil

News

Eylea data gives Regeneron/Bayer a lift in ophthalmic diseas...

A higher dose of Regeneron and Bayer's Eylea given every three or four months has shown efficacy in a pair of clinical trials, in a big boost for the multibillion-dollar product.

Patients

Bayer sets out a proposed basis for science-based self-care ...

The healthcare sector has a “moral imperative” to help people navigate the self-care industry, says pharma giant.

Bayer extends elinzanetant trials to include breast cancer

Bayer get EU nod for extended use of contraceptive Mirena

Bayer's Vividion unit forges $930m cancer alliance with Tavr...

Report claims Bayer is already hunting for a new CEO

Eylea data gives Regeneron/Bayer a lift in ophthalmic diseas...

Bayer sets out a proposed basis for science-based self-care ...

Lilly's 'triple G' retatrutide aces crucial obesity trial

Discover a new era of healthcare panel engagement: Grounded ...

Bayer

Editor's Picks